Related Experiment Videos

Bacteremic community-acquired pneumonia due to viridans group streptococci

T J Marrie1

  • 1Department of Medicine, Dalhousie University, Halifax, Nova Scotia.

Insights

Viridans streptococci rarely cause bacteremic community-acquired pneumonia. This rare infection in pneumonia patients has no distinct clinical or radiographic features, leading to a high mortality rate.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality.
  • Bacteremia complicates CAP in a subset of patients, necessitating identification of causative pathogens.
  • Viridans streptococci are common commensals but rarely implicated as primary pathogens in severe pneumonia.

Observation:

  • A retrospective study analyzed 1118 patients with CAP over 8 years.
  • Blood cultures revealed viridans streptococci in 7 (9.2%) of 76 bacteremic patients.
  • These 7 patients included definite, probable, and possible cases of viridans streptococcal pneumonia.

Findings:

  • The 7 patients with viridans streptococcal bacteremia were older (mean age 61.8 years) with a high mortality rate (28%).
  • Clinical presentation included fever and elevated white blood cell counts.
  • Hypoxemia was common (pO2 34-68 torr), and chest radiographs showed non-specific segmental alveolar opacities.

Implications:

  • Viridans streptococci are an uncommon cause of bacteremic CAP.
  • No specific clinical or radiographic features can reliably identify this etiology.
  • The high mortality underscores the importance of considering less common pathogens in severe pneumonia.

Related Concept Videos